Home/All Molecules/Mefenamic Acid

Mefenamic Acid Range

Comprehensive Mefenamic Acid portfolio for Franchise & Manufacturing.

Category
mefenamic-acid
Total Formulations
16
Available Forms
Injection, Suspension, Tablets

Expand Your Business with Our Multiple Divisions


Browse Mefenamic Acid portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Mefenamic Acid batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Mefenamic Acid PCD Pharma Franchise Company

Mefenamic Acid PCD Pharma Franchise Company

Cafoli Lifecare is a leading Mefenamic Acid PCD pharma franchise company in India, offering 16 Mefenamic Acid formulations manufactured at WHO-GMP certified facilities. The range spans tablets, oral suspensions and injections, covering adult, paediatric and acute-care requirements from a single molecule.

What is Mefenamic Acid?

Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) of the fenamate class. It inhibits cyclo-oxygenase enzymes, reducing prostaglandin synthesis, and thereby produces analgesic, anti-inflammatory and antipyretic effects. It is particularly well established in the management of primary dysmenorrhoea and menorrhagia, where prostaglandin-driven uterine contraction is the underlying mechanism. Compound details are available on PubChem.

Therapeutic Applications

Mefenamic Acid is indicated for primary dysmenorrhoea and menstrual pain, heavy menstrual bleeding (menorrhagia), mild to moderate pain including dental and post-operative pain, musculoskeletal and rheumatic pain, and fever — with paediatric suspensions widely used as antipyretics. It is prescribed by gynaecologists, general physicians, paediatricians, orthopaedic surgeons and dental surgeons.

Why Mefenamic Acid is a High-Potential Molecule for Distributors

What separates Mefenamic Acid from the crowded NSAID field is its gynaecological niche. Most NSAIDs compete head-on in generic pain relief, but Mefenamic Acid is the fenamate of choice for dysmenorrhoea and menorrhagia because it reduces both pain and menstrual blood loss — an indication where it is specified by name rather than substituted on price. That gives a distributor a defensible gynae line while the tablet, suspension and injection forms simultaneously serve paediatric fever and acute pain demand. In practice this means one molecule anchors both the gynae and general-practice doctor lists, with cyclical monthly repeat demand that other analgesics do not have.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive monopoly rights in your allotted territory, WHO-GMP certified and DCGI-approved manufacturing, dependable stock supply, competitive margins, and complete promotional inputs including visual aids, samples, MR bags, catch covers and reminder cards. Our network spans 1000+ franchise partners across India.

References

  1. PubChem — Mefenamic Acid Compound Summary, National Library of Medicine
  2. PubMed — Clinical literature on Mefenamic Acid in dysmenorrhoea

Aceclofenac in Modern Clinical Practice

Our formulations of Mefenamic Acid find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Mefenamic Acid in PCD Franchise

Start Your Mefenamic Acid Franchise with Cafoli Lifecare

Anchor both your gynae and general-practice lists with one molecule and monopoly rights in your district. Call +91 95184 47302 or email info@cafoli.in for the latest Mefenamic Acid price list, packing details and territory availability.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 16 Mefenamic Acid formulations across tablets, oral suspensions and injections, covering adult pain, gynaecological indications and paediatric fever. Call 9518447302 for the current list with packing and pricing.

Yes. Cafoli Lifecare grants exclusive district or territory-level monopoly rights, so no competing franchise partner is appointed in your allotted area for the Mefenamic Acid portfolio. This is confirmed in writing in your agreement.

It is prescribed by gynaecologists for dysmenorrhoea and menorrhagia, and by general physicians, paediatricians, orthopaedic surgeons and dental surgeons for pain and fever.

Most NSAIDs compete head-on in generic pain relief, but Mefenamic Acid is the fenamate of choice for dysmenorrhoea and menorrhagia because it reduces both pain and menstrual blood loss. In that indication it is specified by name rather than substituted on price, giving a distributor a defensible gynae line with cyclical monthly repeat demand.

You need a valid Drug License and a GST registration number. Share these with your preferred territory and our team will confirm availability and send the price list and agreement.